EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration

Christine Manta, Nikhil Mahadevan, Jessie Bakker, Simal Ozen Irmak, Elena Izmailova, Siyeon Park, Jiat-Ling Poon, Santosh Shevade, Sarah Valentine, Benjamin Vandendriessche, Courtney Webster, Jennifer C Goldsack

Digital Biomarkers · 18.05.2021 · 5 (2) · 127-147

DOI: 10.1159/000515835 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digital Biomarkers, online erschienen am 18.05.2021. Verfasst von Christine Manta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Digital Medicine Society, Boston, Massachusetts, USA. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The EVIDENCE (EValuatIng connecteD sENsor teChnologiEs) checklist was developed by a multidisciplinary group of content experts convened by the Digital Medicine Society, representing the clinical sciences, data management, technology development, and biostatistics. The aim of EVIDENCE is to promote high quality reporting in studies where the primary objective is an evaluation of a digital measurement product or its constituent parts. Here we use the terms digital measurement product and connected sensor technology interchangeably to refer to tools that process data captured by mobile sensors using algorithms to generate measures of behavioral and/or physiological function. EVIDENCE is applicable to 5 types of evaluations: (1) proof of concept; (2) verification, (3) analytical validation, and (4) clinical validation as defined by the V3 framework; and (5) utility and usability assessments. Using EVIDENCE, those preparing, reading, or reviewing studies evaluating digital measurement products will be better equipped to distinguish necessary reporting requirements to drive high-quality research. With broad adoption, the EVIDENCE checklist will serve as a much-needed guide to raise the bar for quality reporting in published literature evaluating digital measurements products.

Schlagwörter

Stichwörter der Autor:innen

Connected sensorDigital measuresValidation

Autor:innen und Institutionen

  • Digital Medicine Society, Boston, Massachusetts, USA.
  • Elektra Labs, Boston, Massachusetts, USA.
  • Pfizer Inc., Cambridge, Massachusetts, USA.
  • Philips, Monroeville, Pennsylvania, USA.
  • Tibi Health Inc., San Francisco, California, USA.
  • Koneksa Health Inc., New York, New York, USA.

Zitieren

APA

Manta, C., Mahadevan, N., Bakker, J., Ozen Irmak, S., Izmailova, E., Park, S., Poon, J. L., Shevade, S., Valentine, S., Vandendriessche, B., Webster, C., & Goldsack, J. C. (2021). EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration. Digital Biomarkers, 5(2), 127-147. https://doi.org/10.1159/000515835

Vancouver

Manta C, Mahadevan N, Bakker J, Ozen Irmak S, Izmailova E, Park S, et al. EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration. Digital Biomarkers. 2021;5(2):127-147. doi:10.1159/000515835

BibTeX
@article{Manta2021,
  author = {Manta, Christine and Mahadevan, Nikhil and Bakker, Jessie and Ozen Irmak, Simal and Izmailova, Elena and Park, Siyeon and Poon, Jiat-Ling and Shevade, Santosh and Valentine, Sarah and Vandendriessche, Benjamin and Webster, Courtney and Goldsack, Jennifer C},
  title = {EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration},
  journal = {Digital Biomarkers},
  year = {2021},
  volume = {5},
  number = {2},
  pages = {127--147},
  doi = {10.1159/000515835}
}
Kostenlos starten →